Work

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

Year: 2017

Type: article

Source: Leukemia

DOI: 10.1038/leu.2017.214

Authors: M O Holmström, E Martinenaite, S M Ahmad, Ö Met, C Friese, L Kjær, C H Riley, P thor Straten, I M Svane, H C Hasselbalch, M H Andersen

Institutions: Roskilde Sygehus, Herlev Hospital, Copenhagen University Hospital, Zealand University Hospital, Rigshospitalet, University of Copenhagen

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2731447759

FWCI: 5.887

Cites: 33

Cited by: 93

Related to: 10